Annual revenue:
$30.05B+$566.61M(+1.92%)Summary
- As of today (August 16, 2025), TAK annual revenue is $30.05 billion, with the most recent change of +$566.61 million (+1.92%) on March 1, 2025.
- During the last 3 years, TAK annual revenue has fallen by -$1.71 billion (-5.38%).
- TAK annual revenue is now -5.38% below its all-time high of $31.76 billion, reached on March 31, 2022.
Performance
TAK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$7.66B+$747.36M(+10.81%)Summary
- As of today (August 16, 2025), TAK quarterly revenue is $7.66 billion, with the most recent change of +$747.36 million (+10.81%) on June 1, 2025.
- Over the past year, TAK quarterly revenue has dropped by -$92.87 million (-1.20%).
- TAK quarterly revenue is now -11.76% below its all-time high of $8.68 billion, reached on June 30, 2021.
Performance
TAK Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$29.96B-$92.87M(-0.31%)Summary
- As of today (August 16, 2025), TAK TTM revenue is $29.96 billion, with the most recent change of -$92.87 million (-0.31%) on June 1, 2025.
- Over the past year, TAK TTM revenue has increased by +$401.33 million (+1.36%).
- TAK TTM revenue is now -5.75% below its all-time high of $31.79 billion, reached on March 31, 2022.
Performance
TAK TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.9% | -1.2% | +1.4% |
| 3 y3 years | -5.4% | +2.3% | -2.1% |
| 5 y5 years | -0.7% | +2.7% | -0.1% |
TAK Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.4% | +1.9% | -2.8% | +10.8% | -2.1% | +1.6% |
| 5 y | 5-year | -5.4% | +1.9% | -11.8% | +10.8% | -5.8% | +1.6% |
| alltime | all time | -5.4% | +512.2% | -11.8% | +223.2% | -5.8% | +1007.3% |
TAK Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $7.66B(+10.8%) | $29.96B(-0.3%) |
| Mar 2025 | $30.05B(+1.9%) | $6.91B(-7.9%) | $30.05B(-0.5%) |
| Dec 2024 | - | $7.51B(-4.7%) | $30.22B(-0.0%) |
| Sep 2024 | - | $7.88B(+1.7%) | $30.22B(+2.2%) |
| Jun 2024 | - | $7.75B(+9.5%) | $29.56B(+0.2%) |
| Mar 2024 | $29.49B(-0.8%) | $7.08B(-5.8%) | $29.50B(-0.5%) |
| Dec 2023 | - | $7.51B(+4.1%) | $29.65B(-0.8%) |
| Sep 2023 | - | $7.22B(-6.3%) | $29.89B(-0.1%) |
| Jun 2023 | - | $7.70B(+6.6%) | $29.92B(+0.7%) |
| Mar 2023 | $29.72B(-6.4%) | $7.22B(-6.9%) | $29.71B(-1.0%) |
| Dec 2022 | - | $7.75B(+7.0%) | $30.00B(-0.6%) |
| Sep 2022 | - | $7.25B(-3.3%) | $30.17B(-1.4%) |
| Jun 2022 | - | $7.49B(-0.2%) | $30.60B(-3.7%) |
| Mar 2022 | $31.76B(+5.3%) | $7.51B(-5.3%) | $31.79B(+0.8%) |
| Dec 2021 | - | $7.93B(+3.3%) | $31.54B(-0.3%) |
| Sep 2021 | - | $7.67B(-11.6%) | $31.62B(+0.8%) |
| Jun 2021 | - | $8.68B(+19.6%) | $31.38B(+4.1%) |
| Mar 2021 | $30.15B(-0.4%) | $7.26B(-9.3%) | $30.16B(+0.6%) |
| Dec 2020 | - | $8.01B(+7.7%) | $29.98B(+0.3%) |
| Sep 2020 | - | $7.43B(-0.3%) | $29.88B(-0.4%) |
| Jun 2020 | - | $7.46B(+5.3%) | $30.00B(-0.9%) |
| Mar 2020 | $30.27B(+60.1%) | $7.08B(-10.4%) | $30.27B(+1.9%) |
| Dec 2019 | - | $7.90B(+4.6%) | $29.70B(+13.3%) |
| Sep 2019 | - | $7.56B(-2.2%) | $26.22B(+16.4%) |
| Jun 2019 | - | $7.72B(+18.6%) | $22.53B(+19.0%) |
| Mar 2019 | $18.91B(+18.4%) | $6.51B(+47.0%) | $18.92B(+17.4%) |
| Dec 2018 | - | $4.43B(+14.6%) | $16.12B(+0.7%) |
| Sep 2018 | - | $3.86B(-6.2%) | $16.01B(-0.2%) |
| Jun 2018 | - | $4.12B(+11.3%) | $16.05B(+0.5%) |
| Mar 2018 | $15.97B(-0.1%) | $3.70B(-14.4%) | $15.96B(+0.2%) |
| Dec 2017 | - | $4.32B(+10.8%) | $15.93B(+0.5%) |
| Sep 2017 | - | $3.90B(-3.2%) | $15.85B(-1.1%) |
| Jun 2017 | - | $4.03B(+10.0%) | $16.02B(+0.1%) |
| Mar 2017 | $15.99B(+6.3%) | $3.66B(-13.7%) | $16.01B(+0.4%) |
| Dec 2016 | - | $4.25B(+4.3%) | $15.94B(+1.4%) |
| Sep 2016 | - | $4.07B(+1.2%) | $15.72B(+2.1%) |
| Jun 2016 | - | $4.02B(+11.8%) | $15.39B(+2.3%) |
| Mar 2016 | $15.05B(-7.0%) | $3.60B(-10.7%) | $15.05B(-0.5%) |
| Dec 2015 | - | $4.03B(+7.5%) | $15.13B(-1.6%) |
| Sep 2015 | - | $3.75B(+1.9%) | $15.37B(-3.1%) |
| Jun 2015 | - | $3.68B(+0.0%) | $15.85B(-2.2%) |
| Mar 2015 | $16.18B(-4.2%) | $3.67B(-13.9%) | $16.20B(-1.6%) |
| Dec 2014 | - | $4.27B(+0.8%) | $16.47B(-1.8%) |
| Sep 2014 | - | $4.23B(+5.1%) | $16.77B(+0.0%) |
| Jun 2014 | - | $4.03B(+2.2%) | $16.76B(-0.8%) |
| Mar 2014 | $16.89B(-10.1%) | $3.94B(-13.7%) | $16.89B(-0.3%) |
| Dec 2013 | - | $4.57B(+8.1%) | $16.94B(-2.2%) |
| Sep 2013 | - | $4.23B(+1.7%) | $17.33B(-4.0%) |
| Jun 2013 | - | $4.16B(+4.1%) | $18.05B(-4.3%) |
| Mar 2013 | $18.78B | $3.99B(-19.4%) | $18.87B(-4.1%) |
| Dec 2012 | - | $4.96B(+0.2%) | $19.68B(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $4.94B(-0.6%) | $20.22B(+2.5%) |
| Jun 2012 | - | $4.98B(+3.5%) | $19.73B(+3.1%) |
| Mar 2012 | $19.11B(+15.3%) | $4.81B(-12.6%) | $19.13B(+3.8%) |
| Dec 2011 | - | $5.50B(+23.7%) | $18.44B(+5.8%) |
| Sep 2011 | - | $4.45B(+1.5%) | $17.43B(+1.2%) |
| Jun 2011 | - | $4.38B(+6.6%) | $17.22B(+2.9%) |
| Mar 2011 | $16.57B(+5.0%) | $4.11B(-8.4%) | $16.74B(+2.3%) |
| Dec 2010 | - | $4.49B(+5.8%) | $16.35B(+2.1%) |
| Sep 2010 | - | $4.24B(+9.1%) | $16.01B(+1.4%) |
| Jun 2010 | - | $3.89B(+4.4%) | $15.79B(-0.0%) |
| Mar 2010 | $15.79B(+3.2%) | $3.73B(-10.1%) | $15.79B(+0.9%) |
| Dec 2009 | - | $4.15B(+3.1%) | $15.64B(+0.2%) |
| Sep 2009 | - | $4.02B(+3.4%) | $15.61B(+1.4%) |
| Jun 2009 | - | $3.89B(+8.7%) | $15.40B(+0.8%) |
| Mar 2009 | $15.29B(+27.1%) | $3.58B(-13.0%) | $15.28B(+5.1%) |
| Dec 2008 | - | $4.12B(+7.9%) | $14.53B(+6.4%) |
| Sep 2008 | - | $3.81B(+1.3%) | $13.67B(+7.1%) |
| Jun 2008 | - | $3.77B(+32.8%) | $12.76B(+6.3%) |
| Mar 2008 | $12.03B(+7.8%) | - | - |
| Mar 2008 | - | $2.84B(-12.7%) | $12.00B(+2.7%) |
| Dec 2007 | - | $3.25B(+11.8%) | $11.69B(+1.6%) |
| Sep 2007 | - | $2.90B(-3.6%) | $11.51B(+2.3%) |
| Jun 2007 | - | $3.01B(+19.3%) | $11.26B(+0.6%) |
| Mar 2007 | $11.16B(+4.2%) | - | - |
| Mar 2007 | - | $2.52B(-17.8%) | $11.19B(+1.4%) |
| Dec 2006 | - | $3.07B(+15.8%) | $11.04B(+2.1%) |
| Sep 2006 | - | $2.65B(-10.0%) | $10.81B(+0.9%) |
| Jun 2006 | - | $2.95B(+24.3%) | $10.71B(+0.3%) |
| Mar 2006 | $10.71B(+2.5%) | - | - |
| Mar 2006 | - | $2.37B(-16.6%) | $10.67B(-0.4%) |
| Dec 2005 | - | $2.84B(+11.3%) | $10.71B(-0.8%) |
| Sep 2005 | - | $2.55B(-12.3%) | $10.80B(+1.0%) |
| Jun 2005 | - | $2.91B(+20.7%) | $10.69B(+1.9%) |
| Mar 2005 | $10.45B(+8.7%) | - | - |
| Mar 2005 | - | $2.41B(-17.8%) | $10.49B(+29.8%) |
| Dec 2004 | - | $2.93B(+20.0%) | $8.08B(+56.9%) |
| Sep 2004 | - | $2.44B(-9.7%) | $5.15B(+90.3%) |
| Jun 2004 | - | $2.71B | $2.71B |
| Mar 2004 | $9.61B(+12.0%) | - | - |
| Mar 2003 | $8.58B(+6.7%) | - | - |
| Mar 2002 | $8.04B(-7.7%) | - | - |
| Mar 2001 | $8.71B(+5.1%) | - | - |
| Mar 2000 | $8.29B(+24.7%) | - | - |
| Mar 1999 | $6.65B(-3.1%) | - | - |
| Mar 1998 | $6.86B(-7.7%) | - | - |
| Mar 1997 | $7.43B(-10.6%) | - | - |
| Mar 1996 | $8.31B(+5.9%) | - | - |
| Mar 1995 | $7.85B(+15.3%) | - | - |
| Mar 1994 | $6.81B(+17.1%) | - | - |
| Mar 1993 | $5.81B(+8.6%) | - | - |
| Mar 1992 | $5.35B(+9.0%) | - | - |
| Mar 1991 | $4.91B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual revenue?
- What is the all time high annual revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual revenue year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly revenue?
- What is the all time high quarterly revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly revenue year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM revenue?
- What is the all time high TTM revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM revenue year-on-year change?
What is Takeda Pharmaceutical Company Limited annual revenue?
The current annual revenue of TAK is $30.05B
What is the all time high annual revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual revenue is $31.76B
What is Takeda Pharmaceutical Company Limited annual revenue year-on-year change?
Over the past year, TAK annual revenue has changed by +$566.61M (+1.92%)
What is Takeda Pharmaceutical Company Limited quarterly revenue?
The current quarterly revenue of TAK is $7.66B
What is the all time high quarterly revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly revenue is $8.68B
What is Takeda Pharmaceutical Company Limited quarterly revenue year-on-year change?
Over the past year, TAK quarterly revenue has changed by -$92.87M (-1.20%)
What is Takeda Pharmaceutical Company Limited TTM revenue?
The current TTM revenue of TAK is $29.96B
What is the all time high TTM revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM revenue is $31.79B
What is Takeda Pharmaceutical Company Limited TTM revenue year-on-year change?
Over the past year, TAK TTM revenue has changed by +$401.33M (+1.36%)